| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Stifel reiterates Buy on Envista stock, keeps $31 price target | ||
| Fr | Stifel reiterates Philip Morris stock Buy rating on smoke-free growth | ||
| Fr | Stifel reiterates Intuit stock rating at Hold with $300 target | ||
| Fr | Stifel reiterates HubSpot stock rating on AI adoption uncertainty | ||
| Fr | Stifel cuts Agree Realty stock price target on debt offering terms | ||
| Fr | Joby aircraft completes first autonomous cross-country US flight | ||
| Fr | Philip Morris raises quarterly dividend 8.8% to $1.60 per share | ||
| Fr | ReposiTrak declares quarterly dividend of $0.02 per share | ||
| Fr | Better founder nominates three directors in proxy fight | ||
| Fr | PMGC converts Elevai Skincare royalty into payment plan | ||
| Fr | Enhertu receives EU approval recommendation for early breast cancer | ||
| Fr | VisionWave to implement 1-for-20 reverse stock split Monday | ||
| Fr | Aura Minerals secures $200 million syndicated loan facility | ||
| Fr | Gold.com appoints Jill Van as CFO, names KPMG as auditor | ||
| Fr | Corcept's relacorilant receives EU panel backing for ovarian cancer | ||
| Fr | Needham cuts Xenon Pharmaceuticals stock price target on trial pause | ||
| Fr | DA Davidson lowers Reddit stock price target on user growth concerns | ||
| Fr | Delixy Holdings approves 1-for-5 reverse stock split | ||
| Fr | Tenet Fintech signs framework deal with Bin Zayed subsidiary | ||
| Fr | Ready Capital prices $225M notes, to redeem $350M debt | ||
| Fr | FDA approves Ultragenyx gene therapy for rare disorder MPS IIIA | ||
| Fr | Beneficient plans Q4 launch of alternative asset analytics tool | ||
| Fr | W. P. Carey raises quarterly dividend to $0.950 per share | ||
| Fr | Freedom Capital initiates Cipher Mining stock with hold rating | ||
| Fr | Cantor Fitzgerald raises Ultragenyx stock price target on gene therapy approval |